WASHINGTON, D.C. -- The United States Supreme Court reinstated a requirement enacted by the U.S. Food and Drug Administration (FDA) that women seeking to obtain abortion drugs must pick them up in person from a hospital or medical office rather than receiving them by mail.
The High Court ruled 6-3 in Food and Drug Administration v. American College of Obstetricians and Gynecologists (FDA v. ACOG) that the FDA abortion drug rule may go into effect and lifted a nationwide injunction against it. It granted the FDA request to reinstate enforcement for the “Elements to Assure Safe Use” in the Risk Evaluation Mitigation Strategy (REMS) for the chemical abortion pill mifepristone.
